呼吸器染症に対するbalofloxacinの臨床的検討  [in Japanese] Clinical effect fo balofloxacin in respiratory tractr infections  [in Japanese]

Access this Article

Search this Article

Author(s)

Abstract

呼吸器感染症患者7名に新規経口フルオロキノロン薬balofloxacin 1日200または400mg (分2) を7~14日間投与した。臨床効果は著効2例, 有効5例で有効率100%の成績を得た。本剤に起因すると考えられる副作用または臨床検査値異常変動は全く認められなかった。

Seven patients with respiratory tract infections were treated with balofloxacin, a new oral fluoroquinolone, at a dose of 200 mg or 400 mg (b. i. d.) for 7-14 days.The clinical efficacy was evaluated as excellent in 2 and good in 5 cases. No adverse reactions or abnormalities in laboratory findings due to the treatment were recognized.

Journal

  • Japanese Journal of Chemotherapy

    Japanese Journal of Chemotherapy 43, 547-549, 1995-11-27

    Japanese Society of Chemotherapy

References:  7

Codes

Page Top